Stada Group
Larisa-Endora Radu-Rosu is a skilled professional in the field of quality control and analytical support with experience at STADA Group since August 2022 as Manager Global Quality Control, Analytical Support, and EU Testing. Prior to this role, Radu-Rosu served as an R&D Chemical Analyst at B. Braun Group from September 2019 to March 2022, where responsibilities included autonomously organizing experiments for analytical method validation, conducting statistical evaluations with Microsoft Excel, and determining intravenous medication shelf-life using Minitab. Radu-Rosu holds a Master's degree in Clinical Chemistry (2019-2021) and a Bachelor's degree in Chemistry (2016-2019) from West University of Timisoara.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.